Share

November 12, 2013; 81 (20) Article

Higher glucose levels associated with lower memory and reduced hippocampal microstructure

Lucia Kerti, A. Veronica Witte, Angela Winkler, Ulrike Grittner, Dan Rujescu, Agnes Flöel
First published October 23, 2013, DOI: https://doi.org/10.1212/01.wnl.0000435561.00234.ee
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1328

Share

Article Information

vol. 81 no. 20 1746-1752
DOI: 
https://doi.org/10.1212/01.wnl.0000435561.00234.ee
PubMed: 
24153444
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 7, 2013
  • Accepted in final form August 14, 2013
  • First Published October 23, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Lucia Kerti, MA*,
    2. A. Veronica Witte, PhD*,
    3. Angela Winkler, MA,
    4. Ulrike Grittner, PhD,
    5. Dan Rujescu, MD and
    6. Agnes Flöel, MD
  1. Lucia Kerti, MA*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) German society for neurology, compensation for travel related expenses (conference talks 2010 and 2011)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. A. Veronica Witte, PhD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) German Society for Neurology, travel compensations for conference talks, 2010-12, (2) Alzheimer's Association, travel grant for conference talk, 2012, (3) German National Academic Foundation, compensation for educational course, 2012, (4) Sport-Gesundheitspark Berlin e.V., honoraria for a symposium's talk, 2012

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Federal Ministry of Education and Research, FKZ 0315673, Co-PI, 2010-13

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. German Research Foundation, FL 379/8-1, Co-PI, 2009-present

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Angela Winkler, MA,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) German society for neurology, compensation for travel related expenses (conference talk 2012)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Ulrike Grittner, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. I received funding from the Center for Rusmiddelforskning Aarhus University, Denmark, from the Albrecht-Kossel-Institute for Neuroregeneration Rostock University, Germany and from the Federal Ministry of Education and Research via the Grant Center for Stroke Research Berlin (01 EO 0801).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Dan Rujescu, MD and
    6. Scientific Advisory Boards:

    1. F.Hoffmann-La Roche Advisory Board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. F.Hoffmann-La Roche Advisory Board

    Editorial Boards:

    1. International Journal of Neuropsychopharmacology (CINP) Field Editor for Molecular Psychiatry of the World Journal of Biological Psychiatry BMC Medical Genetics European Neuropsychopharmacology (ECNP) Suizidprophylaxe European Archives of Psychiatry and Clinical Neuroscience

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Agnes Flöel, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Received one-time speaker honoraria (between 500 and 1000 Euro) for oral presentations from Novartis, B?hringer-Ingelheim and Souvenaid (commercial entities). not related to present study

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Royalties from the book ?Alzheimer- Unabwendbares Schicksal?? from 2012 onwards (less than 3000 Euro total) not related to present study

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Received one-time consulting fees from Schwabe (1500 Euro, commercial entity). not related to present study

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Fl 379-8/1, Fl 379-10/1, Fl 279-11/1; and DFG-Exc 257), the Else-Kr?ner Fresenius Stiftung (2009-141 ; 2011-119), and the Bundesministerium f?r Bildung und Forschung (FKZ 0315673A, 01EO0801 and 01GY1144).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (L.K., A.V.W., A.W., A.F.) and Biostatistics and Clinical Epidemiology (U.G.), NeuroCure Cluster of Excellence (A.V.W., A.F.), and Center for Stroke Research Berlin (U.G., A.F.), Charité–University Medicine, Berlin; and Department of Psychiatry (D.R.), University of Halle, Germany.
  1. Correspondence to Dr. Flöel: agnes.floeel{at}charite.de or Ms. Kerti: lucia.kerti{at}charite.de

Article usage

Article usage: October 2013 to October 2023

AbstractFullPdfSource
Oct 201364426177Highwire
Nov 2013589565157Highwire
Dec 20134030282522Highwire
Jan 201418293352Highwire
Feb 20148321624Highwire
Mar 20148111019Highwire
Apr 20146171212Highwire
May 20145671217Highwire
Jun 201453876Highwire
Jul 201410911117Highwire
Aug 2014441911Highwire
Sep 2014586911Highwire
Oct 2014117355Highwire
Nov 201441638Highwire
Dec 2014429711Highwire
Jan 20154351315Highwire
Feb 20153091212Highwire
Mar 201543564Highwire
Apr 201529056Highwire
May 201535413Highwire
Jun 201528577Highwire
Jul 201540368Highwire
Aug 201532265Highwire
Sep 2015381914Highwire
Oct 201545374Highwire
Nov 201529497Highwire
Dec 201527523Highwire
Jan 201635995Highwire
Feb 201630233Highwire
Mar 201637766Highwire
Apr 201628621Highwire
May 201627963Highwire
Jun 201628743Highwire
Jul 201636622Highwire
Aug 201634444Highwire
Sep 201643012Highwire
Oct 201639844Highwire
Nov 201632522Highwire
Dec 201628122Highwire
Jan 2017126300Highwire
Feb 201766501Highwire
Mar 201767535Highwire
Apr 2017110953Highwire
May 2017605107Highwire
Jun 201758003Highwire
Jul 201770635Highwire
Aug 201772412Highwire
Sep 201758742Highwire
Oct 201767832Highwire
Nov 201769810Highwire
Dec 201734122Highwire
Jan 201833711Highwire
Feb 201846575Highwire
Mar 201836586Highwire
Apr 201846042Highwire
May 201836231Highwire
Jun 201828630Highwire
Jul 201830352Highwire
Aug 201825501Highwire
Sep 201828522Highwire
Oct 201832722Highwire
Nov 201839782Highwire
Dec 201841610Highwire
Jan 201945021Highwire
Feb 201934310Highwire
Mar 201931070Highwire
Apr 201941131Highwire
May 201932224Highwire
Jun 201927132Highwire
Jul 201922344Highwire
Aug 201938822Highwire
Sep 201920811Highwire
Oct 2019293229Highwire
Nov 201929174Highwire
Dec 201929512Highwire
Jan 202030315Highwire
Feb 202030722Highwire
Mar 202033701Highwire
Apr 202027200Highwire
May 202029100Highwire
Jun 202026621Highwire
Jul 202024412Highwire
Aug 202025611Highwire
Sep 202027134Highwire
Oct 202024532Highwire
Nov 202023831Highwire
Dec 202027031Highwire
Jan 202122801Highwire
Feb 202123812Highwire
Mar 202161531Highwire
Apr 202172541Highwire
May 202147510Highwire
Jun 202129931Highwire
Jul 202134421Highwire
Aug 202150012Highwire
Sep 202124321Highwire
Oct 202130033Highwire
Nov 202124922Highwire
Dec 202131824Highwire
Jan 202222862Highwire
Feb 202234311Highwire
Mar 202231211Highwire
Apr 202230860Highwire
May 202228600Highwire
Jun 202225022Highwire
Jul 202223314Highwire
Aug 202222000Highwire
Sep 202227100Highwire
Oct 202227723Highwire
Nov 202236603Highwire
Dec 202226901Highwire
Jan 202359222Highwire
Feb 202327400Highwire
Mar 202331911Highwire
Apr 202325242Highwire
May 202327611Highwire
Jun 202322701Highwire
Jul 202333441Highwire
Aug 202323444Highwire
Sep 202325510Highwire
Oct 202325110Highwire

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles